| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/09/1991 | CA1282705C Compositions for treating the symptoms of or preventing the common cold |
| 04/09/1991 | CA1282703C Stable injectable antiemetic compositions |
| 04/09/1991 | CA1282701C Rumen-stable pellets |
| 04/09/1991 | CA1282700C Confectionery delivery system for actives |
| 04/09/1991 | CA1282699C Method for preparing small vesicles using microemulsification |
| 04/09/1991 | CA1282698C Time controlled explosion systems and processes for preparing the same |
| 04/06/1991 | WO1991004667A1 Use of liposomes as carriers for metalloporphyrins |
| 04/06/1991 | CA2042576A1 Use of liposomes as carriers for metalloporphyrins |
| 04/05/1991 | WO1991004752A1 Eye-drops |
| 04/05/1991 | CA2067383A1 Eye-drops |
| 04/04/1991 | WO1991004732A1 Erodible macroporous hydrogel particles and preparation thereof |
| 04/04/1991 | WO1991004039A1 Erection-inducing methods and compositions |
| 04/04/1991 | WO1991004034A1 Topical preparation for treatment of aphthous ulcers and other lesions |
| 04/04/1991 | WO1991004019A1 Therapeutic peptides and proteins |
| 04/04/1991 | WO1991004018A1 Magnesium carbonate and oil tableting aid |
| 04/04/1991 | WO1991004017A1 Film-enrobed unitary-core medicament and the like |
| 04/04/1991 | WO1991004016A1 Implantable delivery dispenser |
| 04/04/1991 | WO1991004015A1 Controlled release composition |
| 04/04/1991 | WO1991004014A1 Method for transporting compositions across the blood brain barrier |
| 04/04/1991 | WO1991004013A1 Hybrid paucilamellar lipid vesicles |
| 04/04/1991 | WO1991004011A1 Medicinal aerosol formulations |
| 04/04/1991 | WO1991004010A1 An external analgesic lotion and method of making |
| 04/04/1991 | WO1991003936A1 Effervescent compositions |
| 04/04/1991 | WO1991002553A3 Transdermal nitroglycerin patch with penetration enhancers |
| 04/04/1991 | WO1991000289A3 Targeted liposomes and methods for liposome-protein coupling |
| 04/04/1991 | WO1990015637A3 Neurological therapy system |
| 04/04/1991 | DE3932100A1 Prodn. of homeopathic medicines - by dilution with ethanol and drying on sugar granules |
| 04/04/1991 | CA2066594A1 Erodible macroporous hydrogel particles and preparation thereof |
| 04/04/1991 | CA2026707A1 Chewable spray dried spheroidal microcapsules and wax coated microcapsules and methods for preparing same |
| 04/04/1991 | CA2026706A1 Chewable spray dried spheroidal microcapsules and polymer coated microcapsules and methods for preparing same |
| 04/03/1991 | WO1991004751A1 Inhibitor of absorption of digestion product of food and drink |
| 04/03/1991 | EP0420798A1 Antimicrobial compositions |
| 04/03/1991 | EP0420785A2 Stable immunogen composition |
| 04/03/1991 | EP0420729A1 Preparation of homogene plant suspension and suspension obtained thereby |
| 04/03/1991 | EP0420722A2 Lipid compounds, derivatives of sphingosines, process for their preparation and their use, especially in cosmetics and in dermopharmaceutics |
| 04/03/1991 | EP0420649A2 Stabilized aqueous formulations of small peptides |
| 04/03/1991 | EP0420600A2 Use of protease inhibitors as antiexudative, antiphlogistic and antimicrobial agents |
| 04/03/1991 | EP0420459A2 Oral pharmaceutical composition for acid sensitive proteinaceous agents |
| 04/03/1991 | EP0420264A2 Transdermal delivery of (+)(2S,3S)-3-acetoxy-8-chloro-5-(2-dimethyl-aminoethyl)-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4-(5H)-one |
| 04/03/1991 | EP0420056A2 Use of fatty acids, fatty acid salts and fatty acid esters of mono-, di- or trihydroxy alkanes |
| 04/03/1991 | EP0420049A1 Stabilized leucocyte-interferon |
| 04/03/1991 | EP0420042A2 Solid pharmaceutical form with a high verapamil content |
| 04/03/1991 | EP0419998A2 Use of alkylphosphonic acid derivatives for the treatment of psoriasis |
| 04/03/1991 | EP0419890A2 Stable pharmaceutical formulations for antineoplastic compounds having more than one ethyleneimine group, and method |
| 04/03/1991 | EP0419759A2 Aluminium, magnesium-hydroxy-fatty acid compounds and thermostable lipogels prepared therewith |
| 04/03/1991 | EP0419563A1 Time release protein. |
| 04/03/1991 | EP0419559A1 Tooth-anchored beneficial agent delivery device. |
| 04/03/1991 | CN1050373A Process for preparing optically active 2-aryl-alkanoic acid, in particular 2-aryl propionic |
| 04/03/1991 | CN1050328A Process for preparing dicarbonhydrase mini-capsule having function to protect digestive tract |
| 04/03/1991 | CN1050327A Protein-containing aqueous solutions |
| 04/03/1991 | CN1050321A Thrombolytic composition containing tissue type plasminogen activator or derivative thereof |
| 04/03/1991 | CN1050320A Pulsatile once-a-day delivery systems for aminotetra cycline |
| 04/03/1991 | CA2067353A1 Inhibitor of absorption of digestion product of food and drink |
| 04/03/1991 | CA2026462A1 Tretinoin emulsified cream formulations of improved stability |
| 04/03/1991 | CA2024781A1 Method for treating systemic candida infections with a single dose administration of amphotericin b lipid complex |
| 04/02/1991 | US5004771 Polyorganosiloxane, alkaline earth metal or alkali organo-siliconate, nonsilicious inorganic filler; storage stability |
| 04/02/1991 | US5004756 Anti-cancer activity potentiator |
| 04/02/1991 | US5004651 Of estropipate and tromethamine |
| 04/02/1991 | US5004614 Drug delivery |
| 04/02/1991 | US5004613 Wet Granulation Process Using Hydroxyethyl Cellulose And Polyvinylpyrrolidone |
| 04/02/1991 | US5004612 Pharmaceutical compositions comprising esters or amides as active ingredients |
| 04/02/1991 | US5004611 Pro-liposome compositions |
| 04/02/1991 | US5004610 Subsaturated nicotine transdermal therapeutic system |
| 04/02/1991 | US5004605 Low pH pharmaceutical compositions of recombinant β-interferon |
| 04/02/1991 | US5004602 Continuous release pharmaceutical compositions formed by freeze drying acetic acid solutions of polylactide |
| 04/02/1991 | US5004601 Low-melting moldable pharmaceutical excipient and dosage forms prepared therewith |
| 04/02/1991 | US5004598 Stable and quick-breaking topical skin compositions |
| 04/02/1991 | US5004595 Multiple encapsulated flavor delivery system and method of preparation |
| 04/02/1991 | CA1282405C Method for making uniformly sized particles from water-insoluble organic compounds |
| 04/02/1991 | CA1282331C Pharmaceutical composition containing cefuroxime axetil |
| 04/02/1991 | CA1282330C Drug depot containing cytostatics |
| 04/02/1991 | CA1282329C Medicament adsorbates with surfactant and their preparation |
| 04/02/1991 | CA1282328C Medicament adsorbates with complex magnesium aluminum silicate and their preparation |
| 04/02/1991 | CA1282327C Slow-release pharmaceutical agent |
| 04/02/1991 | CA1282326C Pharmaceutical composition containing 13-cis vitamin a acid as the active ingredient |
| 04/02/1991 | CA1282321C Emulsifiable concentrates containing azoles |
| 04/02/1991 | CA1282319C Animal bait |
| 03/30/1991 | CA2026508A1 Stable immunogen composition for oral administration |
| 03/30/1991 | CA2026293A1 Transdermal delivery of (+)(2s,3s)-3-acetoxy-8-chloro-5-(2-dimethylaminoethyl)-2,3- dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4-(5h)-one |
| 03/30/1991 | CA2026166A1 Medicamentous form |
| 03/29/1991 | CA2026149A1 Stabilized aqueous formulations of small peptides |
| 03/29/1991 | CA2024046A1 Stabilized leukocyte-interferons |
| 03/28/1991 | WO1991004679A1 Machine and method for the continuous treatment of surfaces of articles of reduced thickness |
| 03/28/1991 | CA2026292A1 Plaque disclosing compositions |
| 03/28/1991 | CA2026283A1 Oral pharmaceutical composition for acid sensitive proteinaceous agents |
| 03/27/1991 | WO1991004733A1 Ibuprofen triturates and topical compositions containing same |
| 03/27/1991 | EP0419252A1 Thrombolytic composition containing tissue type plasminogen activator or derivative thereof |
| 03/27/1991 | EP0419251A1 Protein-containing aqueous solutions |
| 03/27/1991 | EP0419165A2 Preservative for ophthalmic solutions |
| 03/27/1991 | EP0419156A2 Bioerodible thermoset elastomers |
| 03/27/1991 | EP0419121A2 Stabilized antibiotic compositions for animal feeding |
| 03/27/1991 | EP0418806A1 Pharmaceutical compositions havin activity on the cutaneous microcirculation |
| 03/27/1991 | EP0418697A1 Pharmaceutical compositions containing calcitonin |
| 03/27/1991 | EP0418674A1 Pharmaceutical preparations for enhanced absorption of antibacterial compounds |
| 03/27/1991 | EP0418642A1 High-absorbable transvaginal preparation containing biologically active peptides |
| 03/27/1991 | EP0418607A1 Application aid for planar sheet sections |
| 03/27/1991 | EP0418600A1 Method of making xanthin-derivate pellets |
| 03/27/1991 | EP0418597A2 Controlled release carbonic anhydrase inhibitor containing pharmaceutical compositions from spherical granules in capsule oral dosage unit form |
| 03/27/1991 | EP0418596A2 Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form. |
| 03/27/1991 | EP0418582A2 Method for treating hypermotility diseases of the bowel employing an ace inhibitor |